Herbal medicinal product: Meliloti herba, Melilotus officinalis (L.) Lam., C: ongoing call for scientific data
Herbal medicinal product: Lupuli flos, Humulus lupulus L., C: ongoing call for scientific data
Herbal medicinal product: Gentianae radix, Gentiana lutea L., C: ongoing call for scientific data
Human medicines European public assessment report (EPAR): Extavia, interferon beta-1b, Date of authorisation: 20/05/2008, Revision: 26, Status: Withdrawn
Herbal medicinal product: Cisti cretici herba, Cistus creticus L., D: Draft under discussion
Dear Colleagues,
We are working on an adaptation of Clinical Practice Guidelines of Venous Thromboembolism (VTE) Prophylaxis, focusing on most relevant and pragmatic approaches for hospitalized patients.
While selecting the PICO questions we would like to find out what are the most important issues for clinicians, who deal with VTE daily.
This is a 11-question survey about your doubts and aspects, which in your opinion could help you most in managing Venous Thromboembolism Prophylaxis in your patients.
Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 42, Status: Authorised
Human medicines European public assessment report (EPAR): Qtern, saxagliptin,dapagliflozin, Date of authorisation: 15/07/2016, Revision: 14, Status: Authorised
Draft ICH Q1 guideline on stability testing of drug substances and drug products - Step 2b
Dear Fellow Internists,
The Young Internists have developed, along with the Argentinian Society of Internal Medicine, a survey to assess the situation of Gender Equality in Internal Medicine, which has been marked as a relevant topic by the WHO.
We would very much appreciate if you could take a moment of your time to complete it. The survey is anonymous and takes less than 5 minutes to complete.
Please find the link here: